Survey results reveal Australian usage of medicinal cannabis for inflammatory bowel disease. – Brinkwire

  • Results from the anonymous online survey, published in the journal Crohn’s & Colitis, examined IBD severity, medication adherence, quality of life, as well as medicinal cannabis use and its perceived impact on these measures.
  • Crohn’s disease, ulcerative colitis or IBD unclassified; and different cannabis use populations non-user, previous user and current self-prescribed medicinal cannabis users.
  • More than 90 percent of patients reported that medicinal cannabis use improved their symptom management with greatest benefits reported for abdominal pain, stress, sleep, cramping and anxiety symptoms.
  • Both cannabis-using and non-using patients expressed high levels of support for the use of medicinal cannabis in IBD and interest in participating in future clinical trials of medicinal cannabis products.

Read full article: